CEPHALOSPORINS
CEPHALOSPORINS
Introduction
History
Discovery
The first chemical compounds of the cephalosporin
group were isolated from Cephalosporium acremonium, a
cephalosporin-producing fungus first discovered by Giuseppe Brotzu in
1948 from a sewage outfall off the Sardinian coast. From crude filtrates
of the Cephalosporium acremonium culture scientists got new
antibacterial activity. It was noted that the crude filtrate could inhibit the
growth of Staphylococcus aureus.
Further
investigations by Abraham and Newton were made in England
and isolation of culture fluids from the Sardinian fungus yielded cephalosporin
P, N and C. These natural compounds were not found to be potent enough
to use as antimicrobial agents but with chemical methods and removal of the
natural side chain it was possible to produce 7-aminocephalosporanic acid (7-ACA)
which could be further fit with unnatural side chains. 7-ACA is analogous to
6-aminopenicillanic acid (6-APA), a starting block for making several
derivatives of penicillins.
In
1959 Abraham reported that his N-phenylacetyl derivative of cephalosporin C was
much more potent against Staphylococcus aureus strains than the parent
compound. This derivative was later named Cephaloram, a cephalosporin analogue
of benzylpenicillin.
Eli
Lilly developed a method for producing 7-ACA based on cleaving the
α-aminoadipoyl side chain of cephalosporin C. Further work by Robert Morin led
to semisynthesis of 3-deacetoxy-7-ACA (7-ADCA) from penicillins which is
convenient because penicillins can be fermented with more ease than
cephalosporins. For example 7-ADCA can be semisynthesized in seven chemical
reaction steps from phenoxymethylpenicillin.
The cephalosporins
are β-Lactam antibiotics that are closely related both structurally and
functionally to the penicillins. Mechanism of action, mechanism of resistance
and some other properties of cephalosporins are identical to penicillins. Cephalosporins are one of the most widely used antibiotics
and are equal in importance to penicillin. The cephalosporins are isolated from: - Cephalosprium
species; - Prepared semisynthetically.
In 1945 Giuseppe Brotzu`s discovered that
cultures of Cephalosporium acremonium inhibited the growth of a wide
variety of Gram-positive and Gram-negative bacteria. In 1948 Abraham and his
colleagues have been supplied cultures of the fungus and was isolated three
principal antibiotic components:
- Cephalosporin P, (a steroid antibiotic
that resembles fusidic acid) with minimal antibacterial activity.
- Cephalosporin N, later discovered to be
identical with synnematin N (a penicillin derivative now called penicillin N)
- Cephalosporin C.Penicillin N (Cephalosporin N)
*Most of the antibiotics introduced since 1965 have been semisynthetic
cephalosporins.
Cephalosporin C can be
hydrolyzed by acid to 7-aminocephalosporanic acid.
*Compounds containing
7-aminocephalosporanic acid are:
- Relatively
stable in dilute acid.
- Highly resistant
to penicillinase, regardless of the nature
of their side
chains and their affinity for the enzyme.
Basic
structure of cephalosporins
Cephalosporin
C
The core of the basic cephalosporin molecule
consists of a two ring system which includes a β-lactam ring condensed with
dihydrothiazine ring.
The
core itself can also be referred to as 7-aminocephalosporanic acid which
can be derived by hydrolysis from the natural compound cephalosporin
C.
Chemical
compounds containing this core are relatively stable to acid hydrolysis and
tolerance to β-lactamases.
Cephalosporin
C contains a side-chain which is derived from D-aminoadipic acid. Modification
of side chains on the relevant positions has been used to create a whole
new class of cephalosporin antibiotics.
Modification
of side-chains in position 7 of the lactam ring seems to affect the
antibacterial activity while position 3 of the dihydrothiazine ring alters pharmacokinetic
properties and receptor binding affinity.
This compound has been modified by the
addition of different side chains to create a whole family of cephalosporin
antibiotics.
General
Properties
The physical and
chemical properties of the cephalosporins are similar to those of the
penicillins, although the cephalosporins are somewhat more stable to pH and
temperature changes.
Cephalosporins
are weak acids derived from 7-aminocephalosporanic acid. They are used either
as the free base form for PO administration (if acid stable) or as sodium salts
in aqueous solution for parenteral delivery (sodium salt of cephalothin
contains 2.4 mEq sodium/g).
Cephalosporins
also contain a β-lactam nucleus that is susceptible to β-lactamase
(cephalosporinase) hydrolysis. These β-lactamases may or may not also attack
penicillins.
Modifications
of the 7-aminocephalosporanic acid nucleus and substitutions on the sidechains
by semisynthetic means have produced differences among cephalosporins in
antibacterial spectra, β-lactamase sensitivities, and pharmacokinetics.
Antibacterial
Spectrum
Ø First generation
Ø Second generation
Ø Third generation
Ø Fourth generation
Ø Increased
generation number, increased gram negative bacterial susceptibility, increased
b-lactamase resistance, decreased efficacy against gram +
Classification
of cephalosporins
Cephalosporins have been classified as first, second, third and fourth
generation largely on the basis of bacterial susceptibility patterns and
resistance to β- lactamases:
First
generation
|
Second
generation
|
Third
generation
|
Fourth
generation
|
Cephalothin
Cephapirin
Cefazolin
Cephalexin*
Cephradine*
Cefadroxil
|
Cefamandole
Cefuroxime
Cefonicid
Ceforanide
Cefaclor*
Cefoxitin
Cefotetan
Cefprozil*
Cepuroxime axetil*
Cefmetazole
|
Cefotaxime
Ceftizoxime
Ceftriaxone
Ceftazidime
Cefoperazone Cefixime*
Cefpodoxime proxetil*
Ceftibuten*
Cefdinir*
|
Cefepime
Cefpirome
Cefclidin
|
* Oral agents
First
Generation
Ø The first
generation cephalosporins are generally effective against most gram-positive
aerobic cocci and several of the gram-negative bacteria, including E coli and
Proteus, Klebsiella, Salmonella, Shigella, and Enterobacter spp. Cefazolin is
more effective against E coli compared to cephalexin.
Cephalosporinase-producing organisms are not susceptible.
Ø Gram + cocci, gram
- bacilli, oral anaerobes Staphylococcus aureus, Proteus mirabilis, E. coli,
Klebsiella pneumonia
Ø Cefazolin,
Cephalothin (parenteral)
Ø Cephalexin,
Cefadroxil, Cephradine (oral)
Second Generation
Ø The
second-generation cephalosporins have greater activity against gram-negative
organisms but are somewhat less active against gram-positive species. An
exception is cefoxitin, which has excellent efficacy against gram-positive
bacteria and potentially Pseudomonas spp.
Ø Less active
against G+, more G-
Ø Haemophilus
influenzae, Enterobacter aerogenes, Neisseria
Ø Cefaclor,
Cefuroxime axetil (Oral)
Ø Cefamandole,
Cefonicid, Cefuroxime, Cefotetan, Ceforanide (Parenteral)
Ø Cefoxitin-
Bacteroides fragilis
Ø Used with
aminoglycosides for G - bacilli
Third
Generation
Ø It is difficult to
identify trends among third- and fourth-generation cephalosporins
Ø More Gm – bacilli,
Serratia marcescens
Ø Cefixime (Oral)
Ø Cefotaxime
Ø Ceftizoxime
Ø Ceftazidime
Ø Cefoperazone
Ø Ceftriaxone
Ø Cefpodoxime
Fourth
Generation
Ø Similar spectrum
to third generation
Ø More resistance to
b-lactamases
Ø Cefepime
hydrochloride
Cephalosporins
Active Against Methicillin-Resistant Staphylococci
Ø Ceftaroline fosamil
Ø Ceftobiprole
medocaril
Ø Binding to
penicillin-binding protein 2a
5th
generation cephalosporins :
A) Ceftaroline fosamil (prodrug) and
B)
Ceftobiprole medocaril (prodrug)
Most cephalosporins are produced
semisynthetically by the chemical attachment of side chains to
7-aminocephalosporanic acid.
Cephalosporins (7α-H) and cephamycins (7α-OCH3): Most natural cephalosporin and cephamycin are not used clinically for side effects, but semi-synthetic products are used.
Mechanism of
action
PBP are
responsible for cross-linking in the bacterial cell wall. They make peptide
bonds between lysine and alanine. Cephalosporins bind into the reaction site of
PBP’s rendering the enzyme unable to cross-link the bacterial wall giving
bactericidal activity.
The mechanism of resistance of Micro Organisms
Alteration of
binding site.
Decrease
permeability.
Production of
β–lactamase enzymes (enzymatic inactivation).
CLASSIFICATION
OF CEPHALOSPORINS
Grouped into
"generations" based on their spectrum of antimicrobial activity. Newer generation has significantly
greater gram-negative antimicrobial properties. Successive
generations have increased activity against gram-negative bacteria. Cephalosporins are derived from cephalosporin C which is an acid-stable
molecule.
FIRST GENERATION
Are moderate
spectrum agents.
Effective for
treating staphylococcal and streptococcal infections and for skin and
soft-tissue infections, as well as for streptococcal pharyngitis.
Have activity
against some Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis
FIRST
GENERATION CEPHALOSPORINS
Cefadroxil.
Cephalexin.
Cephaloridine.
Cephalothin.
Cephapirin.
Cefazolin.
Cephradine.
SECOND GENERATION
Have a greater
gram-negative spectrum.
More resistant to
beta-lactamase.
Useful agents for
treating upper and lower respiratory tract infections, sinusitis and otitis
media.
Cefoxitin is a
second generation cephalosporin with anaerobic activity.
SECOND
GENERATION CEPHALOSPORINS
Cefaclor.
Cefoxitin.
Cefprozil.
Cefuroxime.
THIRD GENERATION
Have a broad spectrum of activity and
increased activity against gram-negative organisms.
Have excellent activity against most
strains of Streptococcus pneumoniae.
Have activity against Neisseria
gonorrhoeae.
THIRD
GENERATION CEPHALOSPORINS
Cefdinir.
Cefixime.
Cefpodoxime.
Ceftibuten.
Ceftriaxone.
Cefotaxime.
FOURTH GENERATION
Have a greater resistance to beta-lactamases than
the third generation cephalosporins.
Can
cross blood brain barrier and are effective in meningitis.
Cefpirome is more active against
pneumococci.
Activity
against nosocomial pathogens such as Enterobacter and Acinetobacte.
FOURTH
GENERATION CEPHALOSPORINS
Cefepime.
Cefluprenam.
Cefozopran.
Cefpirome.
Cefquinome.
Pharmacokinetics
1- Administration:
All cephalosporins
except cefadroxil, cephalexin, cephradine, cefaclor, cefuroxime axetil,
cefdinir, cefixime and ceftibuten must be administered intravenously because of
their poor oral absorption. Only a few
cephalosporins are acid stable and thus effective when administered PO (eg, cephalexin,
cephradine, cefadroxil, cefpodoxime, and cefachlor). They are usually well
absorbed, and bioavailability values are 75–90%. The others are administered
either IV or IM, with plasma concentrations peaking ∼30 min after injection. Ceftiofur is available in
a sustained-release form; its duration of action is extended by
administration at the base of the ear in food animals.
2- Distribution:
Cephalosporins are
distributed into most body fluids and tissues, including kidneys, lungs,
joints, bone, soft tissues, and the biliary tract, but in general, the volume
of distribution is <0.3 L/kg. However, poor penetration into the CSF, even
in inflammation, is a notable feature of the standard cephalosporins.
Cephalosporins are
substrates for p-glycoprotein efflux from the CNS. The third-generation
cephalosporins (eg, moxalactam) may achieve good penetration into the CSF.
The degree of
plasma-protein binding is variable (eg, 20% for cefadroxil and 80% for
cefazolin). The high degree of protein binding of cefovecin (90% dogs, 99%
cats) contributes to its long elimination half-life (5.5 days in dogs, 6.9 days
in cats). However, drug concentrations in transudate remain above the MIC90
of both Staphyloccocus intermedius and E coli for up to 14 days.
All
of cephalosporins distribute very well into body fluids.
However, several
cephalosporins penetrate into CSF in
sufficient concentration to be
useful for the treatment of meningitis. These include: Cefuroxime (2nd
gen.), ceftriaxone, cefotaxime
and ceftizoxime (3rd gen.).
3. Biotransformation:
Several
cephalosporins (such as cephalothin, cephapirin, ceftiofur, cephacetrile, and
cefotaxime) are actively deacetylated, primarily in the liver but also in other
tissues. The deacetylated derivatives are much less active with the exception
of ceftiofur. Ceftiofur is metabolized to several active metabolites that can
contribute significantly to efficacy. Few of the other cephalosporins
are metabolized to any appreciable extent.
4- Fate:
Elimination occurs
through tubular secretion and/or glomerular filtration. Cefoperazone are
excreted through the bile and are frequently used in patients with renal
insufficiency.
Generally, these
β-lactam antibiotics maintain effective blood concentrations for only 6–8 hr.
Exceptions include ceftiofur, cefpodoxime, and cefovecin.
Elimination,
Distribution, and Clearance of Cephalosporins
|
||||
Cephalosporin
|
Species
|
Elimination
Half-life (min)
|
Volume of
Distribution (mL/kg)
|
Clearance
(mL/kg/min)
|
Cefazolin
|
Horses
|
45
|
188
|
5.5
|
Cefotaxime
|
Sheep
|
25
|
134
|
9.0
|
Cefpodoxime
|
Dog
|
300
|
150
|
|
Cefovecin
|
Dog
|
5.5 days
|
90
|
|
Cephalexin
|
Dogs
|
84
|
—
|
—
|
Cefadroxil
|
Dogs
|
120
|
—
|
—
|
Cats
|
150–180
|
—
|
—
|
|
Ceftiofur
|
Cattle
|
∼360
|
—
|
—
|
Therapeutic
uses
When Gm +ve bacteria is involved a 1st
generation agents is preferable.
When the pathogen is gm –ve and the
infection is serious parentral use of a 3rd generation agent is
recommended.
First generation
cephalosporins are Excellent agents for skin and soft tissue infections due to S.
aureus and S. Pyogenes. A single dose of cefazolin just before
surgery is the preferred as prophylaxis
Second-generation
cephalosporins The second generation
agents have inferior activity against penicillin-resistant
S. pneumoniae compared to either the 3rd generation agents or
ampicillin and therefore should not be used for treatment of meningitis or
pneumonia. In case where Gm -ve bacteria and anaerobes are involved such as
intraabdominal infections, pelvic inflammatory disease and diabetic foot
infection, cefoxitin and cefotetan have been shown to be effective. For
colorectal surgery where prophylaxis for intestinal anaerobes is desired,
cefoxitin or cefotetan (2nd generation) are
preferred.
Third generation
cephalosporins - Third generation cephalosporins have been considered to be the drugs of choice for serious infections
caused by: Klebsiella, Enterobacter, Proteus, Haemophilus species.
Ceftriaxone is now the drug of choice for all form of gonorrhea. Cefotaxime or
ceftriaxone (as part of a 3-drug combination with vancomycin and ampicillin)
are used for the initial treatment of meningitis
in nonimmunocompromised adults and children older than 3 months. Ceftazidime + aminoglycoside is the drug of
choice for Pseudomonas meningitis. The antimicrobial spectrum of cefotaxime
and ceftriaxone is excellent for the treatment of community acquired pneumonia,
i.e. that caused by pneumococci, H. influenzae, S. aureus.
The fourth
generation - The fourth generation are indicated for the empirical treatment of
nosocomial infections where antibiotic resistance due to extended spectrum β-lactamases are anticipated. e.g. cefepime has superior
activity against nosocomial isolates of Enterobacter, Citrobacter compared to ceftazidime
and piperacillin
Therapeutic
Indications and Dose Rates
First-generation
cephalosporins have proved useful, particularly for infections involving
Staphylococcus spp (eg, oral cephalexin for dermatitis) and for surgical
prophylaxis (eg, cefazolin). However, their efficacy appears to be declining
because of emerging resistance, including methicillin-resistant organisms.
Ceftiofur is
approved for use in bovine respiratory disease principally caused by
Pasteurella spp and in urinary tract infections in dogs. Use of ceftiofur for
treatment of soft-tissue infections in dogs is not recommended because proper
dosages and safety have not been documented.
Cefpodoxime (PO)
and cefovecin (SC) also have been approved for use in dogs and dogs and cats,
respectively.
Cephalosporins are
particularly useful for treating infections of soft tissue and bone due to
bacteria that are resistant to other commonly used antibiotics.
Cefazolin (IV) has
been used prophylactically 1 hr before surgery.
More than most
penicillins, cephalosporins may penetrate tissues and fluids sufficiently (CSF
being an exception for most), to be effective in the management of
osteomyelitis, prostatitis, and arthritis.
Oral
cephalosporins are also usually effective in the management of urinary tract
infections, except those due to Pseudomonas aeruginosa.
Cephapirin
benzathine is used for dry-cow therapy, and cephapirin sodium is used in
treatment of mastitis.
Adverse
reactions
The approved
cephalosporins are relatively nontoxic. IM injections can be painful, and
repeated IV administration may lead to local phlebitis. Nausea, vomiting, and
diarrhea may occasionally be seen. Hypersensitivity reactions of several forms
have been seen, with cross-reactivity to penicillin allergies possible.
Superinfection may arise with the use of cephalosporins, and Pseudomonas or
Candida spp are likely opportunistic pathogens.
The most common adverse reactions are:
1- Allergic and hypersensitivity
reactions
2-
A disulfiram-like effect
3-Bleeding: Bleeding can occur
with cefamandole, cefotetan, cefmetazole , moxalactam and cefoperazone (containing
an N-methyl-5- thiotetrazole moiety
at the 3 position) b/c of antivitamin K effects, administration
of the vitamin corrects the problem.
4-
Nephrotoxicity.
Interactions
In vitro
incompatibilities are quite common for cephalosporin and cephamycin
preparations; an exception exists when mixing with weak bases such as
aminoglycosides.
Potential
pharmacokinetic interactions are similar to those of the penicillin group.
Comments
Post a Comment